DBS reduced hemichorea associated with a developmental venous anomaly and microbleeding in STN
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Developmental venous anomaly (DVA) is the most common vascular malformation and is usually asymptomatic. Movement disorders associated with DVA have rarely been reported, except a case of hemichorea and hemiballism caused by DVA in the contralateral putamen associated with hyperglycemia.1 The abnormal movements in that case nearly resolved after treatment with insulin and risperidone. We report a case of DVA who presented with hemichorea without metabolic derangement but microbleeding surrounding the DVA in the contralateral subthalamic nucleus (STN) area. The lesion was unresectable and deep brain stimulation (DBS) of globus pallidus interna (GPi) helped control the pharmacologically refractory symptoms.
Footnotes
Author contributions: Tao Xie: drafting and revising the manuscript for content and analysis of data, intraoperative monitoring, DBS programming. Issam Awad: revising the manuscript for content and analysis of data. Un Jung Kang: revising the manuscript for content and analysis of data. Peter Warnke: revising the manuscript for content and analysis of data, performing the surgery.
Study funding: No targeted funding reported.
Disclosure: T. Xie and I. Awad report no disclosures. U. Kang is on the medical advisory board of CVS/Caremark. P. Warnke reports being Associate Editor of the Journal of Neurology, Neurosurgery and Psychiatry. Go to Neurology.org for full disclosures.
- Received June 26, 2013.
- Accepted in final form October 14, 2013.
- © 2014 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors
Dr. Josep Dalmau and Dr. Mar Guasp
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulationR. Kumar, A.M. Lozano, E. Sime et al.Neurology, August 01, 1999 -
Articles
Randomized trial of deep brain stimulation for Parkinson diseaseThirty-six-month outcomesFrances M. Weaver, Kenneth A. Follett, Matthew Stern et al.Neurology, June 20, 2012 -
Expedited Publication
Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's diseaseR. Kumar, A. M. Lozano, Y. J. Kim et al.Neurology, September 01, 1998 -
Views and Reviews
A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PDR.J. St. George, J.G. Nutt, K.J. Burchiel et al.Neurology, October 04, 2010